Elisabeth Pook

431 total citations
10 papers, 345 citations indexed

About

Elisabeth Pook is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Elisabeth Pook has authored 10 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Genetics. Recurrent topics in Elisabeth Pook's work include Estrogen and related hormone effects (2 papers), Neuroendocrine regulation and behavior (2 papers) and Electrolyte and hormonal disorders (2 papers). Elisabeth Pook is often cited by papers focused on Estrogen and related hormone effects (2 papers), Neuroendocrine regulation and behavior (2 papers) and Electrolyte and hormonal disorders (2 papers). Elisabeth Pook collaborates with scholars based in Germany, China and United States. Elisabeth Pook's co-authors include Peter Kolkhof, Marie‐Edith Rafestin‐Oblin, Stefan Schäfer, U. Pleiß, J. Huyet, Lars Bärfacker, Jérôme Fagart, Alexander Hillisch, Michel Fay and Bernd Riedl and has published in prestigious journals such as Journal of Biological Chemistry, Chemical Communications and Journal of Medicinal Chemistry.

In The Last Decade

Elisabeth Pook

10 papers receiving 338 citations

Peers

Elisabeth Pook
Comparison fields: 5 of 63
  • Molecular Biology 186
  • Endocrinology, Diabetes and Metabolism 140
  • Cardiology and Cardiovascular Medicine 68
  • Genetics 63
  • Pulmonary and Respiratory Medicine 58
Atsumi Tsuji‐Hosokawa Japan
Cristina D’Alessandris Italy
Barak Yahalom United States
Ellen Riehle United States
Meriem Ouni Germany
Sandhya Sanghi United States
Kavee Limbutara United States
Takuya Kubo Japan
Shiuh‐Rong Ho United States
Atsumi Tsuji‐Hosokawa Japan View profile →
Citations per field, relative to Elisabeth Pook
Elisabeth Pook · 1×
Citations per year, relative to Elisabeth Pook
Elisabeth Pook · 1×

Countries citing papers authored by Elisabeth Pook

Since Specialization
Citations

This map shows the geographic impact of Elisabeth Pook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Pook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Pook more than expected).

Fields of papers citing papers by Elisabeth Pook

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabeth Pook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Pook. The network helps show where Elisabeth Pook may publish in the future.

Co-authorship network of co-authors of Elisabeth Pook

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabeth Pook. A scholar is included among the top collaborators of Elisabeth Pook based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabeth Pook. Elisabeth Pook is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
# Title Journal Authors Indexed citations
1 Discovery and Structure-Based Design of Potent Covalent PPARγ Inverse-Agonists BAY-4931 and BAY-0069 Journal of Medicinal Chemistry Douglas L. Orsi, Elisabeth Pook et al. 9
2 Cardiac output improvement by pecavaptan: a novel dual‐acting vasopressin V1a/V2 receptor antagonist in experimental heart failure European Journal of Heart Failure Thomas Mondritzki, Julia Vogel et al. 18
3 ADTRP regulates TFPI expression via transcription factor POU1F1 involved in coronary artery disease Gene Chunyan Luo, Elisabeth Pook et al. 11
4 Non-reducible disulfide bond replacement implies that disulfide exchange is not required for hepcidin–ferroportin interaction Chemical Communications Bernd Riedl, Elisabeth Pook et al. 7
5 Chimeric protein probes for C5a receptors through fusion of the anaphylatoxin C5a core region with a small-molecule antagonist Science China Chemistry Chao Zuo, Weiwei Shi et al. 66
6 Vascular Protection and Decongestion Without Renin–Angiotensin–Aldosterone System Stimulation Mediated by a Novel Dual-Acting Vasopressin V1a/V2 Receptor Antagonist Journal of Cardiovascular Pharmacology Peter Kolkhof, Elisabeth Pook et al. 8
7 Androgen inhibits key atherosclerotic processes by directly activating ADTRP transcription Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease Chunyan Luo, Elisabeth Pook et al. 30
8 A New Mode of Mineralocorticoid Receptor Antagonism by a Potent and Selective Nonsteroidal Molecule Journal of Biological Chemistry Jérôme Fagart, Alexander Hillisch et al. 156
9 The p65 domain from NF-κB is an efficient human activator in the tetracycline-regulatable gene expression system Gene Stefanie Urlinger, Vera Helbl et al. 34
10 Affinities of mAbs to Tet repressor complexed with operator or tetracycline suggest conformational changes associated with induction European Journal of Biochemistry Elisabeth Pook, S Grimm et al. 6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026